Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Plans Tighter Enforcement At State Level To Counter Spread Of Spurious Drugs

This article was originally published in PharmAsia News

Executive Summary

India plans to step-up enforcement as some generic drug manufacturers continue to take shortcuts, ignoring the prospect of harsh penalties under a law passed two years ago.


Related Content

Track And Trace Systems Under Negotiations In India To Protect Industry Reputation
Tighter Legal Provisions Will Deter Spurious Drugs In India But May Be Misused Too, Say Legal Experts





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts